Accelerate Diagnostics, Inc
AXDXDelisted Jul 21, 2025- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0000727207
Accelerate Diagnostics, Inc was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Apr 7, 2025; 43 institutions reported holding it in 13F filings for Q1 2025, worth $3.10M in total; no superinvestor held it.
13F holders, Q4 2021
Institutional positions in Accelerate Diagnostics, Inc as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 107
- +2 vs. Q3 2021
- Shares held
- 23.9M
- +331.6K (+1.4%) vs. Q3 2021
- Total value
- $124.7M
- −$13.4M (−9.7%) vs. Q3 2021
- New holders
- 16
- 45 more added
- Sold out
- 14
- 24 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AXDX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 3 | $2.08K |
| Q1 2025 | 43 | $3.10M |
| Q4 2024 | 47 | $5.69M |
| Q3 2024 | 46 | $8.20M |
| Q2 2024 | 41 | $4.98M |
| Q1 2024 | 46 | $4.55M |
| Q4 2023 | 43 | $9.78M |
| Q3 2023 | 38 | $14.7M |
| Q2 2023 | 51 | $18.0M |
| Q1 2023 | 67 | $17.2M |
| Q4 2022 | 73 | $18.0M |
| Q3 2022 | 84 | $41.2M |
| Q2 2022 | 75 | $18.6M |
| Q1 2022 | 106 | $33.1M |
| Q4 2021 | 107 | $124.7M |
| Q3 2021 | 105 | $138.2M |
| Q2 2021 | 95 | $194.7M |
| Q1 2021 | 99 | $205.1M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Accelerate Diagnostics, Inc; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AXA S.A. | 1,346,019 | $7.03M | 0.02% | −242,329−15.3% | Reduced |
| Baird Financial Group, Inc. | 1,508,069 | $7.87M | 0.02% | +400,169+36.1% | Added |
| Vanguard Group Inc | 1,798,772 | $9.39M | 0.00% | +65,786+3.8% | Added |
| Birchview Capital, LP | 2,252,388 | $11.7M | 7.57% | 00.0% | Unchanged |
| BlackRock Inc. | 2,355,162 | $12.3M | 0.00% | +24,718+1.1% | Added |
| Oracle Investment Management Inc | 3,627,549 | $18.9M | 2.78% | −123,572−3.3% | Reduced |
| IFP Advisors, Inc | 15 | – | – | +15 | New |
| PenderFund Capital Management Ltd. | 0 | $0 | 0.00% | −465,259−100.0% | Sold out |
| Linden Advisors LP | 0 | $0 | 0.00% | −304,500−100.0% | Sold out |
| Selkirk Management LLC | 0 | $0 | 0.00% | −261,993−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −108,593−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −43,438−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −21,535−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −15,336−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −13,650−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −10,740−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −6,000−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −1,065−100.0% | Sold out |
| Concord Wealth Partners | 0 | $0 | 0.00% | −289−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −134−100.0% | Sold out |
| Koshinski Asset Management, Inc. | 0 | $0 | 0.00% | −50−100.0% | Sold out |